NCT05627362Numeric Rating ScaleELAPSCelafibranor
…n the double-blind period (DBP) of the phase II ELMWOOD trial ( NCT05627362), elafibranor (ELA) was well tolerated and improved cholestasis…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT05627362 ×
NCT05627362
This funder is selected. Its supporting articles are shown below.